We are always interested in motivated students and scientists
Contact us to discuss more about potential opportunities.
Group dinner, March 2022
From left: Sigrid S. Skånland, Johanne U. Hermansen, Yanping Yin, Aleksandra Urban
Lab retreat to Tryvannstua with Taskén group, June 2021
CLL-CLUE with own web site and Twitter account, May 2021
From the news
|
Onkologisk Tidsskrift (December 2022):
Zanubrutinib øker PFS mot kronisk lymfatisk leukemi og
småcellet lymfocytært lymfom
|
|
OUS-research (August 2022):
Clinical Cancer Research publication: Functional testing of tumor cells can
predict response to therapy in cancer patients
|
|
VJ HemOnc (March 2022):
Drug sensitivity testing in CLL
|
HealthTalk (March, 2022):
Norske forskere har behandlet den første leukemipasienten med funksjonell presisjonsmedisin
|
|
OUS-research (March, 2022):
Haematologica publication: Cancer patient at OUH received treatment guided
by drug sensitivity testing of tumor cells
|
|
BestPractice Nordic (December, 2021):
MRD ved behandling av KLL - en oppdatering fra ASH
|
|
HealthTalk (April, 2021):
Legemiddelresistens ved kronisk lymfatisk leukemi -
Hva er de underliggende mekanismene, og hvordan kan det foregygges og behandles?
|
|
Oslo Cancer Cluster (March, 2021):
Talking about cancer research and equality
|
|
HealthTalk (December, 2020): 
ASH-konferansen oppsummert med Sigrid Skånland
|
|
 Dagens Medisin (December, 2020):
Samler data om sykehus-pasienter med covid-19 og leukemi
|
|
HealthTalk (December, 2020):
Dette er blodkreft
|
|
HealthTalk (November, 2020):
Kunstig intelligens skal gi blodkreftpasienter bedre behandling og færre bivirkninger
|
|
 OUS-research (October, 2020):
ERA PerMed grant awarded to European consortium led by Sigrid S. Skånland
|
|
 OUS-research (September, 2019):
Personalized prediction of drug dose
|
|
 Medisinbloggen (February, 2019):
Hva er blodkreft?
|
|
 Aftenposten Viten (September, 2019):
Skreddersydd kreftbehandling skåner pasienten
|